Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in EQ — Equillium, Inc.

CIK 1940272 AUSTIN, TX
Back to EQ Full portfolio

Position in EQ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,027,420
+$4,574,102 QoQ
Shares Held
3,758,569
+0.9% QoQ
Ownership
5.93%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#4
of 60 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EQ Over Time

Shares Held

Position Value (USD)

Derivatives in EQ

reported options exposure · as of Jun 30, 2024
CallValue
$6,072
CallShares
8,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. EQ ranks #38 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in EQ

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,027,420 3,758,569
2026-03-31 $7,453,318 3,726,659
2025-12-31 $8,692,520 5,608,078
2025-09-30 $7,950,782 5,559,988
2024-09-30 $6,073 7,318
2024-06-30 $97,134 140,775
2024-06-30 $6,072 8,800
2024-03-31 $23,100 10,000
2024-03-31 $459,170 198,775
2023-12-31 $4,680 6,500